Features of O-GlcNAcylation in other disease products, and c) focus on the event and scientific tests of latest OGA and prospective OGT inhibitors. , 2017). Equally, these resulted in decreased OGT and OGA amounts in affected person-derived fibroblasts and unchanged world protein O-GlcNAcylation as assessed from the RL2 antibody (Willems https://waltp877alv9.wikibuysell.com/user